ReoPro (abciximab) to inhibit blood clotting

January 1996

You'll see more physicians using ReoPro (abciximab) to inhibit blood clotting.

This biotech anti-platelet drug came out earlier this year. It's for patients undergoing balloon angioplasty...to help keep the coronary artery open.

So far it's only approved for high-risk patients. But now there's evidence of an overwhelming benefit in reducing heart attack and death...even after routine cases of angioplasty.

Practical advice for a better career, with unlimited access to CE

Pharmacy Technician's Letter includes:

  • 12 issues every year, with brief articles about new meds and hot topics
  • 120+ CE courses, including the popular CE-in-the-Letter
  • Helpful, in-depth Technician Tutorials
  • Access to the entire archive

Already a subscriber? Log in

Volume pricing available. Get a quote